Tag: CBT > FDA Congress: Page 3

Legislation and Regulation
Federal Legalization Debated During U.S. Senate Hearing
The July 26 hearing was conducted by the Senate Subcommittee on Criminal Justice and Counterterrorism.
July 27, 2022
Senate Hearing Bookerheader
Hiring Cannabis Personnel
Orcosa Appoints Andrew C. von Eschenbach, M.D. and Former Commissioner of the FDA, as Senior Advisor
In his role, Eschenbach will provide strategic counsel on regulatory and public affairs, clinical trial development, and other corporate matters.
July 14, 2022
SAFE Banking Act
‘The Clash Between State and Federal Law in the Cannabis Industry’: 4 Key Takeaways on Federal Policy Reform Efforts
Cozen O’Connor attorneys share insight on where cannabis policy reform might be headed to address the disconnect between federal prohibition and state-legal programs.
June 24, 2022
Uscapitolbuildingandflag Adobestock Credit Andreaizzotti Resized
Interviews & Opinion
Cannabis in the New Year: 5 Key Trends to Watch
Jonathan Havens and Marc Adesso, leaders in Saul Ewing Arnstein & Lehr’s Cannabis Law Practice, share the developments from 2021 that will impact the industry’s outlook in 2022.
December 17, 2021
Cannabis A Dobe Stock Tsareva Olga Resized
Adult-Use Legalization Bill
GOP Congresswoman Mace Spices Up Federal Cannabis Legalization
The South Carolina Republican introduced the States Reform Act, an alternative path to broad cannabis reform.
November 15, 2021
South Carolina Republican Rep. Nancy Mace unveils the States Reform Act during a press conference along with stakeholders, veterans and law enforcement members on Nov. 15 at the U.S. Capitol.
Legislation and Regulation
FDA Balks at CBD Dietary Supplement Application, Maintaining Regulatory Uncertainty
Citing its own approval of CBD as an active ingredient in Epidiolex, the FDA sees the cannabinoid as pharmaceutical constituent.
August 12, 2021
Fda
Top Stories
At the Starting Line
CTPharma worked for five years to launch an FDA-approved clinical trial in partnership with Yale School of Medicine. Now that the company has the go-ahead, the real work begins.
December 18, 2019
Ctpharma
Connecticut
CTPharma Launches FDA-Approved Medical Cannabis Clinical Studies With Human Subjects
Research on alleviating stress and pain in patients to be done in partnership with the Yale School of Medicine.
November 11, 2019
Yale Press 12a
Legislation and Regulation
Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access
This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.
October 25, 2019
Capitol Building
Previous Page
Page 3 of 3